J.P. Morgan Launches New Lifetime Sciences Private Capital Team Concentrating on Investments in Impressive Health care Providers

Stephen Squinto, Ph.D., Gaurav Gupta, M.D. and Anya Schiess join J.P. Morgan as Running Associates

Sector luminaries to act as Strategic Advisors to assistance new staff

NEW YORK, Nov. 1, 2022 /PRNewswire/ — J.P. Morgan Asset Administration these days announced the start of a new everyday living sciences private equity group, Everyday living Sciences Personal Money. The new workforce will devote in both equally early and expansion phase health care companies across various tactics aligned to distinct industry prospects, with a aim on novel therapeutics and systems in various goal areas including Genetic Drugs, Oncology, Neurodegenerative Disease, Unusual Ailments, Autoimmunity, AI/ML platforms, Metabolic Diseases and Neuropsychology.

The new team leverages JPMorgan Chase’s scale, resources, data belongings and health care abilities and sits inside of J.P. Morgan Non-public Funds, a growth fairness and non-public credit score financial investment system. The platform funds the ongoing growth of private firms and faucets into major pre-IPO price development opportunities in the shopper and technologies, climate engineering and life sciences sectors.

J.P. Morgan Asset Administration has hired marketplace qualified Dr. Stephen Squinto as Main Investment decision Officer and Taking care of Partner of Lifetime Sciences Personal Capital. Dr. Squinto joins from OrbiMed Advisors and provides a lot more than 30 decades of experience in the biotechnology firm making and investing space, owning co-founded and constructed many biotechnology companies together with Alexion Prescribed drugs and performing as a critical scientific founder of Regeneron Pharmaceuticals. 

Becoming a member of Dr. Squinto as Co-Handling Associates of the expense method are Dr. Gaurav Gupta and Ms. Anya Schiess. Dr. Gupta started daily life science investment decision agency Ascendant BioCapital and was formerly concerned in non-public fairness investments at OrbiMed Advisors. Ms. Schiess has about 25 many years of practical experience in health care investing and most recently was Co-Founder and Normal Companion of Healthy Ventures. Full biographies are included under.

“Our new Life Sciences Non-public Capital team brings together some of the industry’s most revered biotech investors, operators and founders with J.P. Morgan’s considerable health care ecosystem to capture powerful investment options in the biotech sector, which is on the cusp of a golden age of therapeutic innovation,” mentioned Brian Carlin, Main Government Officer, J.P. Morgan Private Cash. “Through Steve, Gaurav and Anya’s deep firm-constructing encounter, the team will convey a exceptional capacity to spouse with portfolio organizations and incorporate important operational value past financial financial investment.”

“I’m thrilled to join J.P. Morgan to start the Lifetime Sciences Non-public Cash workforce. Our key emphasis will be to supply our traders a differentiated investment system that harnesses our deep operational knowledge to act as legitimate partners to the corporations we commit in – from making sturdy leadership groups, guiding early drug discovery efforts, planning clinical advancement systems, and navigating the regulatory setting through to business start approaches,” mentioned Dr. Stephen Squinto, Main Financial investment Officer, Lifetime Sciences Non-public Cash. “As developments in genomics, biomarkers and info science converge, we are observing firsthand the transformative effects that biomedical innovation can offer you to individuals at all stages of existence and we count on much a lot more to occur in the upcoming 10 years. J.P. Morgan’s existing presence in the healthcare sector will give us a important sourcing advantage as we seek out to establish revolutionary and transformative therapeutics providers.”

In addition to the hiring of Dr. Squinto, Dr. Gupta and Ms. Schiess, the organization has also captivated a team of Strategic Advisors comprised of some of the lifetime sciences industry’s foremost authorities that will aid guideline the financial investment system, support to supply expenditure prospects and give operational skills to J.P. Morgan’s portfolio organizations.  Strategic Advisors incorporate:

• Laurie Glimcher, M.D. – President and CEO, Dana Farber Cancer Institute
• Jeffrey Leiden, M.D., Ph.D. – Govt Chairman, Vertex Prescribed drugs
• Frederic Moll, M.D. – Main Improvement Officer, J&J Medical Products Corporations
• Stephen Oesterle, M.D. – Previous Medtronic SVP, Drugs and Technologies
• Robert Stockman – Previous Chairman, REVA Healthcare

“We continue on to see considerable financial commitment chances across private marketplaces and the launch of our new Lifestyle Sciences Non-public Cash team is the following stage in the evolution of our J.P. Morgan Private Capital platform, harnessing the unparalleled scale and methods of JPMorgan Chase to complement our existing development equity abilities throughout client, technological innovation and sustainability sectors,” stated George Gatch, Main Executive Officer, J.P. Morgan Asset Administration.

Biographies – Executive Crew

Stephen Squinto, Ph.D., was earlier an Government Spouse with OrbiMed. He brings about 30 many years of biotechnology sector working experience. Dr. Squinto was a co-founder of Alexion Prescription drugs, Inc. and served as its Govt Vice President and Chief Global Operations Officer. Prior to 2013, he was Alexion’s World wide Head of Study and Advancement. Whilst at Alexion, Dr. Squinto was liable for the discovery, development and start of several effective biotechnology solutions. From 1988 to 1992, Dr. Squinto held several positions at Regeneron Prescribed drugs, Inc. Prior to Regeneron, he held a joint educational situation at equally the Tulane University and LSU Health-related Schools. He is a recipient of many honors and awards from tutorial and specialist organizations for his scientific function. Dr. Squinto acquired his B.A. in Chemistry and Ph.D. in Biochemistry and Biophysics from Loyola University of Chicago.

Gaurav Gupta, M.D., M.S.E. was earlier the founder of Ascendant BioCapital, a life science investment decision company based in New York. Prior to this, Dr. Gupta was an financial commitment expert at OrbiMed Advisors, and served as a resident in neurological operation at Columbia College Professional medical Center. Above 15 yrs as an entrepreneur and trader, he has co-started, assisted construct, or served on the boards of various early-phase personal biotechnology and clinical device organizations. Dr. Gupta acquired his M.D. from the Stanford University School of Drugs, where he was Paul and Daisy Soros Fellow, and B.S. and M.S.E. in biomedical engineering from Johns Hopkins College.

Anya Schiess joins from Healthy Ventures, where by she was Co-Founder and Standard Spouse. Healthier Ventures is an early-stage enterprise cash agency that invests in health/pharma technological innovation. Earlier, Anya was a undertaking capitalist at Thomas, McNerney & Partners, where she centered on everyday living sciences, such as biopharmaceutics, professional medical gadgets, and genomic know-how. Throughout her career, Anya has invested and been a board member/observer in around 30 organizations. Prior to investing, Anya was a healthcare operator. She led system and business enterprise development for Cardinal Health’s medical companies, distribution, and laboratory firms. Anya also held a number of revenue and marketing leadership roles at Medtronic and launched neurological, cardiovascular, and cardiac rhythm products all over the globe. Anya gained a BA cum laude from Princeton College and an MBA with honors from The Wharton School at the University of Pennsylvania. 

Biographies – Strategic Advisors

Laurie H. Glimcher, M.D. was named President and CEO of the Dana-Farber Cancer Institute in 2016. She is also Director of the Dana-Farber/Harvard Most cancers Heart and the Richard and Susan Smith Professor of Medication at Harvard Professional medical University. Beforehand, she was the Stephen and Suzanne Weiss Dean and Professor of Medication of Weill Cornell Medicine and Provost for Clinical Affairs of Cornell College. Dr. Glimcher is a distinguished immunologist, extensively renowned for her do the job in 1 of the most promising regions of cancer study. She is a Member of the Nationwide Academy of Sciences, the Nationwide Academy of Medication and the American Philosophical Culture, Fellow of the American Academy of Arts and Sciences and the former President of the American Association of Immunologists. She formerly served on the Board of Directors of Bristol-Myers Squibb Pharmaceutical Corporation, GlaxoSmithKline Pharmaceutical Company and the Waters Corporation.  She at the moment serves on the Board of Administrators of Analog Equipment, Inc.

Jeffrey Leiden, M.D, Ph.D., is a medical professional and scientist who has devoted his vocation to enhancing the lives of men and women with major ailments. He at present serves as Vertex’s Executive Chairman and was the Chief Govt Officer and President from 2012 by way of March 2020. He has been a member of Vertex’s board of directors considering the fact that July 2009, chairman of the board of directors given that May 2012, and served as guide independent director from Oct 2010 through December 2011. Prior to signing up for Vertex, Dr. Leiden was a controlling director at Clarus Ventures, a lifetime sciences venture money agency, from 2006 via January 2012. Dr. Leiden was President, Chief Functioning Officer and Chief Scientific Officer of Abbott Laboratories, Prescription drugs Solutions Team, and a member of the board of administrators of Abbott Laboratories from 2000 to 2006. He is an elected member of both equally the American Academy of Arts and Sciences and the Countrywide Academy of Drugs. Dr. Leiden serves as a director of Massachusetts Mutual Life Insurance plan Business and as chairman of Odyssey Therapeutics, a privately held company establishing novel medicines for the treatment method of most cancers and autoimmune health conditions and Casana Health, a privately held property-health monitoring enterprise. He is also chairman of the board of Revolution Healthcare (REVH), a SPAC targeted on providers that make the most of novel systems to revolutionize the therapy and shipping and delivery of mental health care. He is also a member of the MIT CEO Advisory Board, a member of the Harvard Professional medical University Board of Fellows, and chairman of the Massachusetts Competitive Partnership (MACP). Dr. Leiden gained his M.D., Ph.D. and B.A. levels from the College of Chicago.

Frederic (Fred) Moll, M.D. is Chief Growth Officer of J&J Healthcare Gadgets Companies, getting offered his sixth organization, Auris Well being, Inc., to J&J for $5.75 billion in 2019. Fred was the co-founder and CEO of Intuitive Surgical, the world’s major medical robotics business now, with a market place capitalization exceeding $100 billion. Fred is not only thought of the “Father of Robotic Surgery” (obtaining also founded Hansen Health care), Fred conceived and commercialized the early essential merchandise that authorized minimally invasive laparoscopic surgical procedure to be done safely with his invention of the basic safety defend trocar (Endotherapeutics) and balloon distention applications (Origin MedSystems). Fred attended the University of California at Berkeley where by he earned a B.A. degree, acquired his M.D. degree from the University of Washington and attained an M.S. in Management from the Stanford Business enterprise School.

Stephen Oesterle, M.D. served as Medtronic’s Senior Vice President for Medicine and Know-how, was a member of the Medtronic Executive Committee for 14 many years, and now serves on 4 community everyday living sciences/health care boards. By forging interactions with world-wide engineering associates and complex universities, he oversaw lengthy time period internal know-how investments although participating in strategic corporate investments in emerging private firms. He also served as a member of the Business enterprise Enhancement and Strategy Committee that permitted all company acquisitions. Through his tenure at Medtronic Dr. Oesterle served on extra than 20 boards as a director or observer and created a solid and enduring profile for Medtronic in the worldwide enterprise money and private equity communities. Prior to joining Medtronic, he was an affiliate professor at Harvard Professional medical University and working towards interventional cardiologist. Steve acquired his bachelor’s degree with Distinction at Harvard University and his MD at Yale Healthcare University.

Robert (Bob) Stockman’s 40-year occupation in life sciences spans founding and operational roles in 6 everyday living science organizations and 15 yrs of M&A transaction encounter. He serves as a marketing consultant to REVA Health care, a business he founded wherever he served as Chairman & CEO. He led the buyouts of Ioptex, an intraocular lens manufacturer, and two Johnson & Johnson divestitures, “A” Company Orthodontics, Inc. and Critikon Organization, LLC, every of which was subsequently obtained. In addition to REVA, he co-started CentriMed which became the Worldwide Healthcare Trade, which transacts $30 billion of clinic materials nowadays. Bob attended Harvard University and gained his MBA at Dartmouth’s Tuck Faculty of Organization, exactly where he was an Overseer.

About J.P. Morgan International Options & J.P. Morgan Personal Capital

J.P. Morgan Personal Cash delivers customized financing remedies for non-public companies across the cash construction and is comprised of a advancement fairness arm and a personal credit score business. The platform’s expansion equity solutions span the buyer, technology, life sciences and local weather changeover sectors. In private credit rating, the crew specializes in corporate and asset-dependent lending, from distressed and distinctive situations to accomplishing financial loans. J.P. Morgan Personal Capital is section of J.P. Morgan World wide Alternatives, the alternative investment arm of J.P. Morgan Asset Management. With extra than 50 a long time as an alternate options investment supervisor, US$208 billion in property under management and a lot more than 800 pros (as of June 30, 2022), J.P. Morgan provides procedures throughout the different financial investment spectrum which includes serious estate, private equity, personal credit history, hedge money, infrastructure, transportation, timber and liquid alternate options. Functioning from offices in the course of the Americas, Europe and Asia Pacific, our independent option expenditure engines merge specialist information and singular focus with the worldwide attain, vast assets and highly effective infrastructure of J.P. Morgan to aid meet up with each client’s precise objectives.

About J.P. Morgan Asset Administration

J.P. Morgan Asset Management, with assets beneath management of USD 2.3 trillion (as of 30 September 2022), is a world wide leader in financial investment administration. J.P. Morgan Asset Management’s clientele contain establishments, retail buyers and significant net worth people today in every single important sector in the course of the earth. J.P. Morgan Asset Administration provides worldwide expenditure administration in equities, fastened revenue, genuine estate, hedge cash, personal fairness and liquidity. For additional details: www.jpmorgan.com/am 

J.P. Morgan Asset Management is the internet marketing name for the asset management small business of JPMorgan Chase & Co. and its investment advisor affiliates around the globe.

Substance ID: 09n8222610201555

Source J.P. Morgan Asset Management